Bixiye
P51-16 Addition of a Drug (Belviq XR) to the Weight Loss Agents Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2016
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 3191 - 3200 ee natiijooyinka 3273
Bixiye
P50-16 Addition of a Drug (Xiidra) to the Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo barnaamijka: Okt 28, 2016
Bixiye
P49-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Zavesca
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2016
Bixiye
QP29-16 Implementation of New Utilization Management Platform
Taariikhda uu dhaqangalayo barnaamijka: Okt 26, 2016
Bixiye
P48-16 Criteria Changes to Certain Services on the Prior Authorization List for MHCP Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 26, 2016
Bixiye
QP28-16 Reminders for Providers who Provide Interpreter Services for MHCP Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 14, 2016
Bixiye
QP27-16 Information Available in Provider Press Publication
Taariikhda uu dhaqangalayo barnaamijka: Okt 12, 2016
Bixiye
P47-16 New Drug-Related Prior Authorization Requirements for Botulinum Toxin, Remicade, Rituxan and Biologic Immunomodulators
Taariikhda uu dhaqangalayo barnaamijka: Okt 10, 2016
Bixiye
P46-16 Changes in Medical Policy IV-87 Spinal Fusion: Lumbar
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 30, 2016
Bixiye
QP26-16 Claims Filing Rules for Air Ambulance Providers
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2016